13F filer · CIK 1697748 ↗

ARK Invest

You are looking at Q3 2025. See the latest, Q2 2026 →

Reported value

$16.80B

+23% on the quarter before

Positions

196

14 new · 9 sold out

Top 10

46.2%

of the value

Est. gain

+$1.96B

on stocks held all quarter

Est. return

+15.6%

on those stocks since Q2 2025

Filed

Nov 12, 2025

On SEC EDGAR ↗

Positions as of Sep 30, 2025, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2025. Striped tiles are options.

172 others31%
Tesla9.5%Coinbase4.8%
Roku Inc4.4%
Palantir4.4%Roblox4.4%Robinhood4.3%
Shopify Inc4.3%
Crispr Therapeutics Ag3.8%
Tempus AI3.4%AMD2.9%Circle2.3%
Bitmine Immersion Technologies2.3%
Teradyne2.2%Kratos Defense2.0%
Archer Aviation Inc1.8%
Beam Therapeutics Inc1.6%
Amazon1.6%
Ark 21shares Bitcoin ETF1.4%
Meta1.3%
Brera Holdings Plc1.3%
Nvidia1.3%TSMC1.2%
Intellia Therapeutics Inc1.2%
Block1.2%

Largest buys

Since Q2 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Bitmine Immersion Technologies~$387.9MNew · 0.0% → 2.3%+7,469,813 shares
  2. Tesla~$227.8MAdded · 7.2% → 9.5%+512,158 shares
  3. Brera Holdings Plc~$218.4MNew · 0.0% → 1.3%+7,279,620 shares
  4. Bullish~$163.9MNew · 0.0% → 1.0%+2,576,709 shares
  5. Exact Sciences Corp~$119.6MAdded · 0.0% → 0.7%+2,186,132 shares
  6. Teradyne~$75.4MAdded · 1.4% → 2.2%+548,140 shares
  7. AMD~$56.6MAdded · 2.8% → 2.9%+349,806 shares
  8. Beam Therapeutics Inc~$53.2MAdded · 1.1% → 1.6%+2,190,993 shares
  9. Alphabet~$50.0MAdded · 0.2% → 0.5%+205,190 shares
  10. Genedx Holdings Corp~$48.2MNew · 0.0% → 0.3%+446,979 shares

Largest sells

Since Q2 2025, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Robinhood~$396.4MCut · 5.3% → 4.3%−2,768,820 shares
  2. Roblox~$201.8MCut · 5.2% → 4.4%−1,456,477 shares
  3. Guardant Health Inc~$126.7MCut · 1.1% → 0.3%−2,028,263 shares
  4. Roku Inc~$111.0MCut · 5.5% → 4.4%−1,108,222 shares
  5. Kratos Defense~$82.5MCut · 1.5% → 2.0%−903,364 shares
  6. Coinbase~$76.8MCut · 6.7% → 4.8%−227,610 shares
  7. Draftkings Inc~$38.6MCut · 1.4% → 0.8%−1,031,565 shares
  8. Shopify Inc~$34.7MCut · 4.3% → 4.3%−233,675 shares
  9. Block~$30.2MCut · 1.5% → 1.2%−418,240 shares
  10. Crispr Therapeutics Ag~$25.6MCut · 3.6% → 3.8%−395,617 shares

Holdings

As of Sep 30, 2025. Changes are in shares against Jun 30, 2025, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
TeslaCommon Stock · shares +17% · price +40.0%9.5%$1.60B+$391.0M
CoinbaseCommon Stock · shares −8.7% · price −3.7%4.8%$808.5M−$31.1M
Roku IncCommon Stock · shares −13% · price +13.9%4.4%$736.1M+$90.0M
PalantirCommon Stock · shares −1.0% · price +33.8%4.4%$736.1M+$186.0M
RobloxCommon Stock · shares −22% · price +31.7%4.4%$735.9M+$177.0M
RobinhoodCommon Stock · shares −36% · price +52.9%4.3%$718.3M+$248.6M
Shopify IncCommon Stock · shares −4.6% · price +28.8%4.3%$715.7M+$160.2M
Crispr Therapeutics AgCommon Stock · shares −3.9% · price +33.2%3.8%$634.3M+$158.3M
Tempus AICommon Stock · shares −3.3% · price +27.0%3.4%$579.2M+$123.2M
AMDCommon Stock · shares +13% · price +14.0%2.9%$494.7M+$53.9M
CircleCommon Stock · shares +1.5% · price −26.9%2.3%$393.4M−$142.4M
Bitmine Immersion TechnologiesCommon Stock · shares New2.3%$387.9M—
TeradyneCommon Stock · shares +25% · price +53.1%2.2%$374.7M+$103.8M
Kratos DefenseCommon Stock · shares −20% · price +96.7%2.0%$329.3M+$161.9M
Archer Aviation IncCommon Stock · shares +5.8% · price −11.7%1.8%$299.9M−$37.6M
Beam Therapeutics IncCommon Stock · shares +25% · price +42.7%1.6%$267.9M+$64.2M
AmazonCommon Stock · shares +6.8% · price +0.1%1.6%$267.6M+$205,274
Ark 21shares Bitcoin ETFETP · shares −4.5% · price +6.2%1.4%$240.4M+$14.1M
MetaCommon Stock · shares +2.7% · price −0.5%1.3%$219.1M−$1.1M
Brera Holdings PlcCommon Stock · shares New1.3%$218.4M—
NvidiaCommon Stock · shares +15% · price +18.1%1.3%$217.5M+$29.0M
TSMCADR · shares +6.2% · price +23.3%1.2%$207.2M+$36.9M
Intellia Therapeutics IncCommon Stock · shares −8.4% · price +84.1%1.2%$205.8M+$94.0M
BlockCommon Stock · shares −14% · price +6.4%1.2%$193.2M+$11.6M
Twist Bioscience CorpCommon Stock · shares +5.1% · price −23.5%1.1%$189.3M−$55.4M
Total · 196 positions100%$16.80B+$1.96B
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2025 to Q3 2025: 182 stocks held throughout, up $1.96B (+15.6%).

  1. Tesla+$391.0M+40%
  2. Robinhood+$248.6M+53%
  3. Palantir+$186.0M+34%
  4. Roblox+$177.0M+32%
  5. Kratos Defense+$161.9M+97%
  6. The Trade Desk−$33.9M−32%
  7. Archer Aviation Inc−$37.6M−12%
  8. Twist Bioscience Corp−$55.4M−24%
  9. Iridium Communications Inc−$67.8M−42%
  10. Circle−$142.4M−27%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$60.00B$30.00B$0
Q4 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$15.40B+20%SEC ↗
Q1 2026$12.86B−15%SEC ↗
Q4 2025$15.07B−10%SEC ↗
Q3 2025$16.80B+23%SEC ↗
Q2 2025$13.64B+37%SEC ↗
Q1 2025$9.99B−17%SEC ↗
Q4 2024$12.01B+10%SEC ↗
Q3 2024$10.93B−3%SEC ↗
Q2 2024$11.27B−22%SEC ↗
Q1 2024$14.44B−14%SEC ↗
Q4 2023$16.89B+29%SEC ↗
Q3 2023$13.07B−13%SEC ↗
Q2 2023$15.10B+4%SEC ↗
Q1 2023$14.55B+26%SEC ↗
Q4 2022$11.54B−20%SEC ↗
Q3 2022$14.35B−15%SEC ↗
Q2 2022$16.91B−29%SEC ↗
Q1 2022$23.96B−28%SEC ↗
Q4 2021$33.08B−21%SEC ↗
Q3 2021$41.64B−23%SEC ↗
Q2 2021$53.74B+7%SEC ↗
Q1 2021$50.34B+34%SEC ↗
Q4 2020$37.59B+123%SEC ↗
Q3 2020$16.86B+81%SEC ↗
Q2 2020$9.30B+132%SEC ↗
Q1 2020$4.01B+1%SEC ↗
Q4 2019$3.96B−13%SEC ↗
Q3 2019$4.58B+15%SEC ↗
Q2 2019$3.97B+13%SEC ↗
Q1 2019$3.50B+42%SEC ↗
Q4 2018$2.46B−26%SEC ↗
Q3 2018$3.31B+21%SEC ↗
Q2 2018$2.73B+36%SEC ↗
Q1 2018$2.01B+60%SEC ↗
Q4 2017$1.26B+53%SEC ↗
Q3 2017$819.3M+60%SEC ↗
Q2 2017$513.6M+48%SEC ↗
Q1 2017$346.9M+26%SEC ↗
Q4 2016$274.9MSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.